OBZ · Class II — Moderate Risk (510(k) clearance required) · Immunology · 21 CFR 866.5130
Classification
FDA Product Code
OBZ
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.5130
Review panel
IM
Medical specialty
Immunology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
Y
Definition
The alpha-1-antitrypsin qualitative phenotype test result is used as an aid in the diagnosis of alpha-1-antitrypsin deficiency in conjunction with clinical and other laboratory findings. For in vitro diagnostic use only.